NCT07407283 2026-02-12A Clinical Study of SHR-4394 in Combination With Anti-tumor Therapy in Prostate CancerJiangsu HengRui Medicine Co., Ltd.Phase 1/2 Not yet recruiting100 enrolled
NCT07209163 2025-10-06Combination Therapy With Tazemetostat in Relapsed and Refractory Peripheral T-cell LymphomaRuijin HospitalPhase 1/2 Not yet recruiting48 enrolled